In contrast, ZMC1 treatment in tp53-/- ERMS cohorts did not affect tumor growth (Figure 4—figure supplement 2H and K, p=0.961) or apoptosis (Figure 4—figure supplement 2I and J, p=0.583). This evidence concerns the gene TP53 and neoplasm.